SEEL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Seelos Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.39 USD -27.79% Market Closed

Market Cap: $100k

	Seelos Therapeutics Inc NASDAQ:SEEL	US
	Bellsystem24 Holdings Inc F:B24	JP
C	Carlsberg A/S F:CBGB	DK
	Xiaomi Corp F:3CP	CN
	HAL Trust F:HA4	MC
K	Keel Infrastructure Corp NASDAQ:KEEL	US
	Canopy Growth Corp TSX:WEED	CA
T	thyssenkrupp AG XHAM:TKA	DE
	Daitron Co Ltd TSE:7609	JP
V	Verastem Inc F:2VS	US
	Tomra Systems ASA OSE:TOM	NO
N	Nomura Real Estate Master Fund Inc TSE:3462	JP
N	Nine Dragons Paper (Holdings) Ltd OTC:NDGPY	HK
C	Celanese Corp SWB:DG3	US
	FINEOS Corporation Holdings PLC OTC:FNCHF	IE

Profitability Summary

Seelos Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1.480%

Negative 3Y Average Operating Margin

-2.671%

Operating Margin is Increasing

-4.856% > -1.480%

Exceptional Net Margin

203%

Negative 3Y Average Net Margin

-2.657%

Net Margin is Increasing

-7.097% > 203%

Negative Free Cash Flow Margin

-659%

Negative 3Y Average Free Cash Flow Margin

-1.693%

Free Cash Flow Margin is Increasing

-3.533% > -659%

Negative ROE

-11%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

1.399%

ROIC is Increasing

-1.274% > 426%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.